Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
59.82
+0.90 (1.53%)
At close: Aug 21, 2026, 4:00 PM EDT
59.77
-0.05 (-0.08%)
Pre-market: Aug 24, 2026, 4:50 AM EDT
Enliven Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 18, 2026 |
| Barclays | Barclays | Buy Initiates $78 | Buy | Initiates | $78 | +30.39% | Aug 18, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $62 → $73 | Buy | Maintains | $62 → $73 | +22.03% | Aug 17, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $82 | Buy | Reiterates | $82 | +37.08% | Aug 13, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $60 → $70 | Buy | Reiterates | $60 → $70 | +17.02% | Aug 7, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $60 → $75 | Buy | Maintains | $60 → $75 | +25.38% | Aug 6, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $70 | Buy | Reiterates | $70 | +17.02% | Aug 6, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $80 → $78 | Buy | Maintains | $80 → $78 | +30.39% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.